Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis‐dependent mechanism

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International Journal of Cancer

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.10440PMID 12115596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Book Review: Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval

  2004cited by this paper
• Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

  2001cited by this paper
• Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.

  2001cited by this paper
• In vitro antitumor activity of cerivastatin, a novel and potent HMG‐CoA reductase inhibitor

  2001cited by this paper
• Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin

  2000cited by this paper
• Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.

  2000cited by this paper
• Current perspectives on statins.

  2000cited by this paper
• Growth in use of statins after trials is not targeted to most appropriate patients

  2000cited by this paper
• Lovastatin and tumor necrosis factor‐α exhibit potentiated antitumor effects against Ha‐ras‐transformed murine tumor Via inhibition of tumor‐induced angiogenesis

  1999cited by this paper
• Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

  1999cited by this paper
• Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.

  1999cited by this paper
• Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

  1999cited by this paper
• Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.

  1999cited by this paper
• Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.

  1999cited by this paper
• Novel Ras antagonist blocks human melanoma growth.

  1999cited by this paper
• Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice.

  1998cited by this paper
• Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group.

  1998cited by this paper
• Lovastatin induces apoptosis in malignant mesothelioma cells.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme.

  1998cited by this paper
• Re: Greying of America will foster new strategies in oncology.

  1998cited by this paper
• Tourniquet infusion chemotherapy for extremity in-transit lesions in malignant melanoma

  1997cited by this paper
• In Vivo Methods for Screening and Preclinical Testing

  1997cited by this paper
• Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).

  1997cited by this paper
• Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

  1996cited by this paper
• Mevalonic Acid Is Limiting for N-Linked Glycosylation and Translocation of the Insulin-like Growth Factor-1 Receptor to the Cell Surface

  1996cited by this paper
• HMG–CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P–glycoprotein–expressing cells

  1996cited by this paper
• Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.

  1995cited by this paper
• Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein.

  1994cited by this paper
• Protein prenylation: a mediator of protein-protein interactions.

  1993cited by this paper
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis.

  1993cited by this paper
• Inhibitors of Ras farnesyltransferases.

  1993cited by this paper
• Inhibition of pancreatic adenocarcinoma cell growth by lovastatin.

  1992cited by this paper
• Inhibition of cell growth by lovastatin is independent of ras function.

  1991cited by this paper
• Cell cycle-specific effects of lovastatin.

  1991cited by this paper

• Investigation of simvastatin and fluvastatin permeation across cell membrane models using molecular dynamics simulations.

  2025cites this paper
• Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia

  2023cites this paper
• The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review

  2023cites this paper
• Repurposing drugs targeting metabolic diseases for cancer therapeutics.

  2023cites this paper
• In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy

  2022cites this paper
• Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins

  2021cites this paper
• The antagonistic atorvastatin-glibenclamide interactions suppressed the atorvastatin-induced Bax/cytochrome c/p53 mRNA expressions and increased Rho A mRNA expression in B16f10 melanoma cell culture

  2021cites this paper
• Targeting the DNA damage response (DDR) by natural compounds.

  2020cites this paper
• MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.

  2020cites this paper
• Pleiotropic effects of statins: a focus on cancer.

  2020cites this paper
• ANTI-MELANOMA BIO-EFFICACY OF THE PLANT MADHUCA LONGIFOLIA AND ITS ENHANCEMENT USING BIOACTIVE PRINCIPLE LOADED GOLD NANOPARTICLE

  2020cites this paper
• Synergistic cytotoxic effect of sodium dichloroacetate combined with chemotherapeutic drugs on B16F10 murine melanoma cell line.

  2019cites this paper
• In Vivo and in Vitro Demonstration of Gold Nanorod Aided Photothermal Presoftening of B16F10 Melanoma for Efficient Chemotherapy Using Doxorubicin Loaded Graphene Oxide.

  2018cites this paper
• The role of lipid signaling in the progression of malignant melanoma

  2018cites this paper
• Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?

  2018cites this paper
• Synergistic Activation of Doxorubicin against Cancer : A Review

  2018cites this paper
• Statins: a new approach to combat temozolomide chemoresistance in glioblastoma

  2018cites this paper
• Pre-clinical analysis of fluvastatin as a metastasis-prevention agent in breast cancer

  2017cites this paper
• Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth

  2017cites this paper
• Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells

  2017cites this paper
• Gamma-tocotrienol reverses multidrug resistance of breast cancer cells with a mechanism distinct from that of atorvastatin.

  2017cites this paper
• Preoperative statin use is not associated with improvement in survival after glioblastoma surgery.

  2016cites this paper
• Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma

  2016cites this paper
• Matrix Metalloproteinases in Asthma-Associated Airway Remodeling – Dr. Jekyll or Mr. Hyde ?

  2016cites this paper
• ACUTE LEUKEMIAS XV

  2015cites this paper
• Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.

  2015cites this paper
• Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma

  2015cites this paper
• Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells

  2015cites this paper
• Antimelanoma Potential of Eruca sativa Seed Oil and its Bioactive Principles

  2015cites this paper
• Biodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma Model

  2014cites this paper
• Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction.

  2014cites this paper
• Preclinical Potentiators of Statin-induced Anticancer Effects

  2014cites this paper
• Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

  2014cites this paper
• Akt signaling and coordinated changes in the distribution and expression of akt-regulating phosphatases

  2014cites this paper
• Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.

  2014cites this paper
• Autocrine secretion of 15d‐PGJ2 mediates simvastatin‐induced apoptotic burst in human metastatic melanoma cells

  2014cites this paper
• Statins: A New Hope for Cancer Therapy

  2013cites this paper
• Effect of atorvastatin and methotrexate on solid Ehrlich tumor.

  2013cites this paper
• The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms

  2013cites this paper
• HIGH DOSE SIMVASTATIN AS A POTENTIAL ANTICANCER THERAPY IN LEUKEMIA PATIENTS

  2013cites this paper
• Synergistic induction of apoptosis by sulindac and simvastatin in A549 human lung cancer cells via reactive oxygen species-dependent mitochondrial dysfunction.

  2013cites this paper
• Antioxidant and Antimutagenic Activities of Isothiocyanates Rich Seed Oil of Eruca sativa Plant

  2012cites this paper
• Targeting tumor cell metabolism with statins

  2012cites this paper
• Chemoprevention of melanoma.

  2012cites this paper
• Antitumor effects of the combination of cholesterol reducing drugs.

  2011cites this paper
• Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.

  2011cites this paper
• Phytochemical potential of Eruca sativa for inhibition of melanoma tumor growth.

  2011cites this paper
• Combinatorial strategies employing nutraceuticals for cancer development

  2011cites this paper
• PHENOTYPICAL CHARACTERIZATION OF BOTRYTIS CINEREA PERS. STRAINS ISOLATED FROM ORNAMENTAL PLANTS

  2011cites this paper
• Inhibitory potential of the ethanol extract of Annona reticulata Linn. against melanoma tumor

  2011cites this paper
• Overcoming multidrug-resistance in cancer: statins offer a logical candidate.

  2010cites this paper
• A Role For Lipid Rafts In Egfr Tki Resistance In Breast Cancer

  2010cites this paper
• Statins can modulate effectiveness of antitumor therapeutic modalities

  2010cites this paper
• Statins in dermatology

  2010cites this paper
• Fluvastatin increases tyrosinase synthesis induced by UVB irradiation of B16F10 melanoma cells.

  2010cites this paper
• RhoC in melanoma: possible target for statin treatment

  2010cites this paper
• Statin-induced cellular effects mediated by the P2X7 receptor

  2009cites this paper
• Targeting the mevalonate pathway for improved anticancer therapy.

  2009cites this paper
• RESEARCH PAPER Autocrine amplification loop in statin-induced apoptosis of human melanoma cells

  2009cites this paper
• Autocrine amplification loop in statin‐induced apoptosis of human melanoma cells

  2009cites this paper
• Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells

  2009cites this paper
• RETRACTED ARTICLE: Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Expression in Cutaneous Malignant Melanomas as a New Molecular Marker of Aggressive Tumor

  2009cites this paper
• Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells

  2008cites this paper
• Überwindung der zelladhäsionsvermittelten Chemo- resistenz durch Hemmung des Mevalonat- Signalweges beim Multiplen Myelom

  2008cites this paper
• Statins-mediated inhibition of rho GTPases as a potential tool in anti-tumor therapy.

  2008cites this paper
• Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models

  2008cites this paper
• Statins in prevention and therapy of cancer

  2008cites this paper
• The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells

  2008cites this paper
• Development of monoclonal antibodies for the identification of novel invasion associated targets in human cancer.

  2008cites this paper
• Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models.

  2008cites this paper
• WP760, a melanoma selective drug

  2007cites this paper
• Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro

  2007cites this paper
• Tocotrienols Potentiate Lovastatin-Mediated Growth Suppression In Vitro and In Vivo

  2007cites this paper
• Statins as a new therapeutic approach in dedifferentiated thyroid cancer?

  2006cites this paper
• Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.

  2006cites this paper
• Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.

  2006cites this paper
• A disconnect between antitumor and antiangiogenic effects of fluvastatin in vitro and in vivo.

  2006cites this paper
• In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation.

  2006cites this paper
• Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

  2006cites this paper
• In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline: Involvement of caspase cascades and IκBα phosphorylation

  2006cites this paper
• Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs

  2006cites this paper
• The role of statins in cancer therapy.

  2006cites this paper
• Lovastatin-induced apoptosis in human melanoma cell lines

  2005cites this paper
• Lipid‐lowering agents and risk of melanoma

  2005cites this paper
• Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.

  2005cites this paper
• Statins and cholesterol lowering after a cancer diagnosis: why not?

  2005cites this paper
• Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells

  2005cites this paper
• Statins in Critical Illness

  2005cites this paper
• The role of statins in cancer prevention and treatment.

  2005cites this paper
• The potential of statins as part of anti-cancer treatment.

  2005cites this paper
• Cutaneous melanoma: pathogenesis and rationale for chemoprevention.

  2005cites this paper
• HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).

  2005cites this paper
• Statins and fibrates for preventing melanoma.

  2005cites this paper
• Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice

  2004cites this paper
• The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase.

  2004cites this paper
• Statins sentence thyroid cancer cells to death rho.

  2003cites this paper
• Cell-Cycle Gene Expression in Lovastatin-Induced Medulloblastoma Apoptosis

  2003cites this paper
• Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells

  2003cites this paper
• Potential antitumor effects of statins (Review).

  2003cites this paper
• Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation

  2003cites this paper